1,5,9-Triazacyclododecane, 3-methylene-1,5-bis[(4-methylphenyl)sulfonyl]-9-(phenylmethyl)- (Cyclotriazadisulfonamide, CADA) is a specific CD4-targeted HIV entry inhibitor; it inhibits the co-translational translocation of CD4 into the endoplasmic reticulum lumen via a signal peptide-dependent pathway; it is also a Sec61 translocon inhibitor.